Related references
Note: Only part of the references are listed.Circulating tumor cells Exploring intratumor heterogeneity of colorectal cancer
Cristina Raimondi et al.
CANCER BIOLOGY & THERAPY (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Single cell analysis of cancer genomes
Peter Van Loo et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Technologies for detection of circulating tumor cells: facts and vision
Catherine Alix-Panabieres et al.
LAB ON A CHIP (2014)
Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials
Christine Fritsch et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G. Lohr et al.
NATURE BIOTECHNOLOGY (2014)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Reliable Single Cell Array CGH for Clinical Samples
Zbigniew T. Czyz et al.
PLOS ONE (2014)
Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
Filip Janku et al.
CELL REPORTS (2014)
Tumor heterogeneity in the clinic: is it a real problem?
Filip Janku
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
Recent Advances in the Molecular Characterization of Circulating Tumor Cells
Lori E. Lowes et al.
CANCERS (2014)
The Role and Clinical Relevance of Disseminated Tumor Cells in Breast Cancer
Malgorzata Banys et al.
CANCERS (2014)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma
Sapna P. Patel et al.
CANCER (2013)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
Francesco Fabbri et al.
CANCER LETTERS (2013)
Genomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients
Mark Jesus M. Magbanua et al.
CANCER RESEARCH (2013)
Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
Takehiko Yokobori et al.
CANCER RESEARCH (2013)
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
Ellen Heitzer et al.
CANCER RESEARCH (2013)
Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
Klaus Pantel et al.
CANCER RESEARCH (2013)
Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
Christin Gasch et al.
CLINICAL CHEMISTRY (2013)
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
Bianca Mostert et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
Helen Schneck et al.
MOLECULAR ONCOLOGY (2013)
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients
Xiaohui Ni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
Chun-Liang Chen et al.
PROSTATE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay
Wael Harb et al.
TRANSLATIONAL ONCOLOGY (2013)
Next-generation sequencing of disseminated tumor cells
Elen K. Moller et al.
FRONTIERS IN ONCOLOGY (2013)
Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
K. Sakaizawa et al.
BRITISH JOURNAL OF CANCER (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer
Randi R. Mathiesen et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Integrated genomic analyses of ovarian carcinoma (vol 474, pg 609, 2011)
J. G. Vockley et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell et al.
PLOS ONE (2012)
PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
Jeanette Dupont Jensen et al.
CLINICAL CANCER RESEARCH (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Clinical relevance and biology of circulating tumor cells
Natalia Bednarz-Knoll et al.
BREAST CANCER RESEARCH (2011)
Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
Y. Kataoka et al.
ANNALS OF ONCOLOGY (2010)
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
K. Ameri et al.
BRITISH JOURNAL OF CANCER (2010)
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
Kevin Kalinsky et al.
CLINICAL CANCER RESEARCH (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
AmirAli H. Talasaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients
Glenn Deng et al.
BREAST CANCER RESEARCH (2008)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene
Claudia I. Mueller et al.
LEUKEMIA RESEARCH (2007)
Mutational hotspot in Exon 20 of PIK3CA in breast cancer among Singapore Chinese
Xiaohui Liang et al.
CANCER BIOLOGY & THERAPY (2006)
Somatic mutation and gain of copy number of PIK3CA in human breast cancer
GJ Wu et al.
BREAST CANCER RESEARCH (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells
A Ulmer et al.
CLINICAL CANCER RESEARCH (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combined transcriptome and genome analysis of single micrometastatic cells
CA Klein et al.
NATURE BIOTECHNOLOGY (2002)
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
O Solakoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer
S Tórtola et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
